IDO1 and neoplasm: The dMMR component presented a high tumour exonic mutational burden (TMB) with 11.0 mutations per megabase, 0.78% unstable loci (which correspond to a microsatellite instable status), and a high expression of IDO, CTLA-4 and PD-1 (Additional file 2).